Study of Biological Determinants of Bleeding Postpartum (HPP-IPF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02884804|
Recruitment Status : Completed
First Posted : August 31, 2016
Last Update Posted : August 31, 2016
At the entry of the delivery room, a standard blood analysis will be performed (Blood count, PT, aPTT, Fibrinogen, and D-Dimer) for each women (if they are agree), according to the center's practices.
The percentage of the immature platelets is a an additional parameter on the hemogram.
The clinical assessments (recorded in medical records) and biological values will be used to determine if there is a correlation between these data and the occurrence of postpartum hemorrhage.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||3599 participants|
|Official Title:||Study of Biological Determinants of Bleeding Postpartum : Predictive Role in the Number of Immature Platelets|
|Study Start Date :||November 2011|
|Actual Primary Completion Date :||May 2015|
|Actual Study Completion Date :||May 2015|
- Postpartum Hemorrhage [ Time Frame: Volume of blood loss up to 24 hours after delivery and / or weight compresses collected at delivery, and / or diagnosis of the clinician ]
- Percentage of immature platelets [ Time Frame: Percentage of immature platelets just before the entry in the birth room ]
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02884804
|CHRU de BREST|
|Principal Investigator:||PAN-PETESCH Brigitte, Dr.||CHRU de BREST|